{"id":"https://openalex.org/W2331368560","doi":"https://doi.org/10.1097/00004714-200002000-00011","title":"Laboratory Measures of Methylphenidate Effects in Cocaine-Dependent Patients Receiving Treatment","display_name":"Laboratory Measures of Methylphenidate Effects in Cocaine-Dependent Patients Receiving Treatment","alternate_titles":[],"publication_year":2000,"publication_date":"2000-02-01","ids":{"openalex":"https://openalex.org/W2331368560","doi":"https://doi.org/10.1097/00004714-200002000-00011","mag":"2331368560","pmid":"https://pubmed.ncbi.nlm.nih.gov/10653210"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-200002000-00011","doi":"https://doi.org/10.1097/00004714-200002000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200002000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2331368560"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087899369","display_name":"John D. Roache","orcid":"https://orcid.org/0000-0002-7010-8119","observed_orcids":["https://orcid.org/0000-0002-7010-8119"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John D. Roache","raw_affiliation_strings":["Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, Houston, USA. roache@uthscsa.edu","Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","[email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, Houston, USA. roache@uthscsa.edu","institution_ids":[]},{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"[email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032888712","display_name":"John G. Grabowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Grabowski","raw_affiliation_strings":["Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","[email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"[email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036001319","display_name":"Joy M. Schmitz","orcid":"https://orcid.org/0000-0002-3561-4614","observed_orcids":["https://orcid.org/0000-0002-3561-4614"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joy M. Schmitz","raw_affiliation_strings":["Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","[email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"[email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018842794","display_name":"Daniel L. Creson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel L. Creson","raw_affiliation_strings":["Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","[email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"[email\u00a0protected]","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112137612","display_name":"Howard M. Rhoades","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Howard M. Rhoades","raw_affiliation_strings":["Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","[email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse-Medications Development Research Center, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Texas Mental Sciences Institute, and the University of Texas Houston Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"[email\u00a0protected]","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087899369"],"corresponding_institution_ids":["https://openalex.org/I919571938"],"apc_list":null,"apc_paid":null,"fwci":1.6758,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.82205902,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"20","issue":"1","first_page":"61","last_page":"68"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.8119999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.8119999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.09709999710321426,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.03849999979138374,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":1.0},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.6579999923706055},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.5559999942779541},{"id":"https://openalex.org/keywords/dysphoria","display_name":"dysphoria","score":0.8130000233650208},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.8859999775886536},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.6809999942779541},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.39100000262260437},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.8991022109985352},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.6893225908279419},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6389265656471252},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.6144789457321167},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5677119493484497},{"id":"https://openalex.org/C2780421500","wikidata":"https://www.wikidata.org/wiki/Q290620","display_name":"Dysphoria","level":3,"score":0.5570536255836487},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.47549188137054443},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.47403931617736816},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.45563119649887085},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.4449884593486786},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.44166290760040283},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4156424403190613},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.40778404474258423},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.383074551820755},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36597681045532227},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.342861145734787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22804602980613708},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.12047278881072998},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-200002000-00011","doi":"https://doi.org/10.1097/00004714-200002000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200002000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10653210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10653210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G5796170645","display_name":"Substance Abuse Research - Medications Development Center","funder_award_id":"P50DA009262","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8311044289","display_name":null,"funder_award_id":"DA-9262","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W54728729","https://openalex.org/W1501655549","https://openalex.org/W1969055588","https://openalex.org/W1972552587","https://openalex.org/W1994652698","https://openalex.org/W1998334153","https://openalex.org/W1999016165","https://openalex.org/W2005139633","https://openalex.org/W2009608813","https://openalex.org/W2017312379","https://openalex.org/W2025702178","https://openalex.org/W2031424202","https://openalex.org/W2034021331","https://openalex.org/W2047423810","https://openalex.org/W2062830458","https://openalex.org/W2070796637","https://openalex.org/W2074689143","https://openalex.org/W2080215367","https://openalex.org/W2081890219","https://openalex.org/W2082876366","https://openalex.org/W2082927185","https://openalex.org/W2091487897","https://openalex.org/W2095217951","https://openalex.org/W2096513892","https://openalex.org/W2116795024","https://openalex.org/W2146835230","https://openalex.org/W2171847439","https://openalex.org/W2172219495","https://openalex.org/W2237298827","https://openalex.org/W2335022712","https://openalex.org/W2475242121","https://openalex.org/W4252506173","https://openalex.org/W4254335951","https://openalex.org/W4301419529","https://openalex.org/W4322694690"],"related_works":["https://openalex.org/W1988174896","https://openalex.org/W1966490087","https://openalex.org/W2000405340","https://openalex.org/W1998668774","https://openalex.org/W2031424202","https://openalex.org/W2081935098","https://openalex.org/W2013568408","https://openalex.org/W2091487897","https://openalex.org/W2072946923","https://openalex.org/W2292932636"],"abstract_inverted_index":{"Two":[0],"experiments":[1],"examined":[2],"the":[3,66,93,104,126,141,148,173,178,193,265,287],"effects":[4,106,115,175,289],"of":[5,28,109,128,147,172,182,221,244,267,275,290],"methylphenidate":[6,58,223,291],"in":[7,13,39,65,72,120,177,192,212,226,239],"male":[8],"and":[9,60,100,113,123,138,185,218,231,246],"female":[10],"patients":[11,35,201],"enrolled":[12],"an":[14,86,227,298],"outpatient":[15,73,194,197],"treatment":[16,59,198,266],"program":[17],"for":[18,43,297],"primary":[19],"cocaine":[20,157,251,268],"dependence.":[21],"The":[22],"first":[23,37,63],"study":[24,211],"was":[25,76,181,188],"a":[26,29,40,79,110,134,206],"component":[27],"double-blind":[30,208],"efficacy":[31],"trial":[32],"wherein":[33],"57":[34],"were":[36,50,107,116,202,224],"tested":[38],"human":[41,67,179,209],"laboratory":[42,68,180,210],"their":[44,62],"initial":[45],"responsiveness":[46],"to":[47,53,118,264],"medication.":[48],"Patients":[49],"randomly":[51],"assigned":[52],"receive":[54],"either":[55],"placebo":[56],"or":[57,167,253,278],"received":[61],"dose":[64,82,90],"environment":[69],"before":[70],"continuing":[71,191],"treatment.":[74],"Methylphenidate":[75,96,153,235],"given":[77],"as":[78],"20-mg":[80],"sustained-release":[81],"(twice":[83],"daily)":[84],"plus":[85],"additional":[87],"5-mg":[88],"immediate-release":[89,222],"combined":[91],"with":[92],"morning":[94],"dose.":[95],"increased":[97],"heart":[98,240],"rate":[99],"subjective":[101,105,242,288],"ratings;":[102],"however,":[103],"primarily":[108],"\"dysphoric\"":[111],"nature,":[112],"significant":[114],"limited":[117],"increases":[119,238],"anxiety,":[121],"depression,":[122],"anger":[124],"on":[125,133,140],"Profile":[127],"Mood":[129],"States;":[130],"shaky/jittery":[131],"ratings":[132,160,243],"visual":[135],"analog":[136],"scale;":[137],"dysphoria":[139],"lysergic":[142],"acid":[143],"diethylamide":[144],"(LSD)":[145],"scale":[146],"Addiction":[149],"Research":[150],"Center":[151],"Inventory.":[152],"did":[154],"not":[155,271,293],"increase":[156],"craving":[158,252],"nor":[159],"suggesting":[161],"abuse":[162,280],"potential":[163],"(i.e.,":[164],"Morphine-Benzedrine":[165],"Group":[166],"drug-liking":[168],"scores,":[169],"etc.).":[170],"None":[171],"drug":[174],"observed":[176],"clinical":[183],"concern,":[184],"no":[186],"subject":[187],"precluded":[189],"from":[190],"study.":[195],"After":[196],"completion,":[199],"12":[200],"brought":[203],"back":[204],"into":[205],"second":[207],"which":[213],"three":[214],"doses":[215],"(15,":[216],"30,":[217],"60":[219],"mg)":[220],"administered":[225],"ascending":[228],"series":[229],"preceded":[230],"followed":[232],"by":[233],"placebo.":[234],"produced":[236],"dose-related":[237],"rate,":[241],"shaky/jittery,":[245],"LSD/dysphoria":[247],"without":[248],"significantly":[249],"altering":[250],"stimulant":[254,261],"euphoria":[255],"ratings.":[256],"These":[257],"results":[258],"suggest":[259,285],"that":[260,286],"substitution-type":[262],"approaches":[263],"dependence":[269],"are":[270],"necessarily":[272],"contraindicated":[273],"because":[274],"cardiovascular":[276],"toxicity":[277],"medication":[279],"potential.":[281],"However,":[282],"they":[283],"also":[284],"may":[292],"be":[294],"positive":[295],"enough":[296],"adequate":[299],"replacement":[300],"approach.":[301]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2331368560","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
